Altria sues FDA over tobacco product review system

Marlboro-maker Altria is seeking to force the FDA to overhaul a review process it says has blocked newer nicotine products from reaching the market.

Published by
CNBC
Published
Length
224 words · 1 min
Altria sues FDA over tobacco product review system

In this article

Follow your favorite stocksCREATE FREE ACCOUNTPacks of Marlboro cigarettes are displayed at a smoke shop on April 28, 2023 in San Francisco, California. Justin Sullivan | Getty Images

Marlboro-maker Altria sued the U.S. Food and Drug Administration on Wednesday, seeking to force the agency to overhaul a review process it says has blocked newer nicotine products from reaching the market, a legal filing showed.

Under U.S. law, the FDA must review new tobacco products before they can be sold, assessing through an application process whether they provide a net public health benefit, such as helping smokers quit.

In a complaint filed in the federal court in Lubbock, Texas, Altria argued the FDA's approach had buried products such as its On! nicotine pouches in regulatory red tape, while allowing foreign competitors that ignored the rules to gain market share.

Altria asked the court to set aside the current system and require the FDA to develop a new one.

Among its arguments, the company said the FDA's approach violates a legal requirement that the agency decide on applications within 180 days of receiving them, a deadline Altria said the FDA has never met.

The FDA did not immediately respond to a request for comment.

Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.

Where this came from

This story was first published by CNBC on 2 Sep 2026. HUE Legacy Ventures did not write it.

Carried in full with attribution and a link to the original. Rights remain with the publisher, who may request removal at any time.

Read it at cnbc.com →